Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

Fabrice Muscari

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6754-1686; OpenAlex author ID A5024004757. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 4 papers · 2025: 1 paper

Papers 13

  1. Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study. Co-author DOI 10.1016/j.esmogo.2025.100144↗
  2. Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prosp… Co-author DOI 10.1016/j.ebiom.2024.105373↗
  3. Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients. Co-author DOI 10.1038/s41598-024-76903-y↗
  4. Influence of pancreatic fistula on survival after upfront pancreatoduodenectomy for pancreatic ductal adenocarcinoma: multicentre retrospective study. Last author DOI 10.1093/bjsopen/zrae125↗
  5. Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project. Co-author DOI 10.1186/s12885-024-12463-8↗
  6. Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. Co-author DOI 10.15252/emmm.202013502↗
  7. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes. Co-author DOI 10.1053/j.gastro.2019.12.009↗
  8. A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score. Last author DOI 10.3390/cancers12040783↗
  9. Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers11060852↗
  10. Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities. Co-author DOI 10.1016/j.ejca.2015.11.012↗
  11. KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma. First author DOI 10.1038/ctg.2016.18↗
  12. KRAS Mutations and Their Correlation With Survival of Patients With Advanced Pancreatic Cancer First author DOI 10.1097/mpa.0b013e31826b388b↗
  13. Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples. Co-author DOI 10.1016/j.pan.2011.12.003↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Barbara Bournet · 8 shared papers, 2012–2024 · strength 0.77
  2. Louis Buscail · 7 shared papers, 2012–2024 · strength 0.58
  3. Pierre Cordelier · 7 shared papers, 2012–2024 · strength 0.58
  4. Charlotte Maulat · 4 shared papers, 2019–2024 · strength 0.56
  5. Cindy Canivet · 3 shared papers, 2020–2024 · strength 0.47
  6. Catherine Alix‐Panabières · 2 shared papers, 2019–2024 · strength 0.29
  7. L. Chiche · 2 shared papers, 2019–2024 · strength 0.28
  8. Bruno Costa‐Silva · 1 shared paper, 2024 · strength 0.19
  9. Thomas Bardol · 1 shared paper, 2024 · strength 0.19
  10. Fanny Castanet · 1 shared paper, 2024 · strength 0.18
  11. Emmanuel Cuellar · 1 shared paper, 2024 · strength 0.18
  12. Jonathan Garnier · 1 shared paper, 2024 · strength 0.18
  13. Olivıer Turrini · 1 shared paper, 2024 · strength 0.18
  14. Gabriella Pittau · 1 shared paper, 2024 · strength 0.18
  15. Alain Sauvanet Sauvanet · 1 shared paper, 2024 · strength 0.18
  16. Christophe Laurent · 1 shared paper, 2024 · strength 0.18
  17. António Sá Cunha · 1 shared paper, 2024 · strength 0.18
  18. Naïma Hanoun · 1 shared paper, 2024 · strength 0.18
  19. Eric Assénat · 2 shared papers, 2016–2020 · strength 0.15
  20. Étienne Buscail · 1 shared paper, 2019 · strength 0.10
  21. Sandrine Dabernat · 1 shared paper, 2019 · strength 0.10
  22. Bertrand Napoléon · 1 shared paper, 2020 · strength 0.10
  23. Stéphanie Truant · 1 shared paper, 2020 · strength 0.10
  24. Célia Cintas · 1 shared paper, 2021 · strength 0.09
  25. Chiara Falcomatà · 1 shared paper, 2021 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.